The choice of antimicrobial therapy among physicians in the treatment of gestational pyelonephritis by Chuhareva, N. A. et al.
Chuhareva N.A., Bontsevich R.A., ,Shchurovskaya K.V., Denisova D.S. The choice of 
antimicrobial therapy among physicians in the treatment of gestational pyelonephritis. 
Research result: pharmacology and clinical pharmacology. Vol. 2, №3 (2016): 46-50. 
46 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
CLINICAL PHARMACOLOGY 
UDC: [656.071.61:616.08](470.325) 
Chuhareva N.A. 
1 
Bontsevich R.A. 
2 
Shchurovskaya K.V.
3 
Denisova D.S.
4 
THE CHOICE OF ANTIMICROBIAL THERAPY AMONG PHYSICIANS 
IN THE TREATMENT OF GESTATIONAL PYELONEPHRITIS 
1) FGBU Scientific Center for Obstetrics, Gynecology and Perinatology. Academician VI Kulakov Russian Ministry of
Health, 4, Oparin street, Moscow, Russian Federation, 117997, e-mail: chuhareva@mail.ru 
2) NRU BSU, dep. pharmacology; Multidisciplinary clinic "Harmony Health" – the center of the safe pharmacotherapy
pregnant and nursing; Belgorod, 85 Pobedy St., Belgorod, 308015, Russian Federation, e-mail: bontsevich@bsu.edu.ru 
3) NRU BSU, dep. pharmacology, Belgorod, 85 Pobedy St., Belgorod, 308015, Russian Federation, e-mail:
572804@bsu.edu.ru 
4) NRU BSU, Belgorod, 85 Pobedy St., Belgorod, 308015, Russian Federation, e-mail: 562158@bsu.edu.ru
Annotation. From 1 to 10% of the physiological pregnancy complicated by acute 
pyelonephritis. The purpose work- analyze the choice of antimicrobial therapy among 
physicians in the treatment of gestational pyelonephritis. Materials and methods-analysis of 
the anonymous survey in the framework of the second stage of the All-Russian 
pharmacoepidemiological study, "Epidemiology of the use of drugs in pregnant women", which 
was conducted from February to April 2015. On the basis of this was carried out to compare the 
results with the results of the survey of doctors of the Belgorod region. Results and discussion. 
Approximately half of the doctors choose the treatment of pyelonephritis in pregnant 
cephalosporins of generations II and III, as well as amoxicillin / clavulanate. Up to 30% of 
physicians prescribe ineffective in this case macrolides. A third of doctors sent patients for 
treatment to other specialists. Conclusion. An analysis of the responses of doctors tactics 
purpose of antimicrobial therapy in gestational pyelonephritis showed that only half of 
practitioners prescribed therapy based on the rational use of antimicrobials. 
Keywords: pregnancy, pyelonephritis, protected penicillins, cephalosporins II and III 
generation, rational pharmacotherapy. 
Introduction: 
Gestational pyelonephritis – an inflammatory 
process that occurs in the interstitial kidney tissue 
and renal pelvis system, which can occur during 
pregnancy, childbirth or the postpartum period. The 
prevalence of the disease is sufficiently large – noted 
that during gestation they suffer from 1 to 10% of 
women [1, 2]. Acute pyelonephritis is the most 
common inflammatory process (10-12%) [3, 4, 5] 
occurring in the kidney during pregnancy. 
It is believed that a woman's body becomes 
more susceptible to the disease during pregnancy for 
many reasons – a violation of passage of urine by the 
ureters iz-za hormonal changes (relaxation of smooth 
muscles of the ureter, renal pelvis expansion of the 
system under the influence of progesterone, the 
occurrence of vesicoureteral reflux) , compression of 
the ureter enlarged uterus (particularly common in 
nulliparous due to the elasticity of muscles anterior 
abdominal wall) [6], the strong growth of pathogenic 
microflora under the influence of estrogens [2, 4, 7]. 
Under the influence of these causes may occur 
stagnation of urine with infection and the 
development of gestational pyelonephritis. 
The causative agents of pyelonephritis well 
understood – most often found in the urine of 
pregnant microorganisms of the family 
Enterobacteriaceae (88%) [3, 4], the most typical 
representatives of which is Escherichia coli (E. coli) 
(65%) [3, 8], seldom – Klebsiella spp. (10%), Proteus 
spp, even rarer – Enterococcus faecalis (4,6%) [4, 7]. 
Gestational pyelonephritis and worsens the 
prognosis of pregnancy and can cause premature 
delivery, hypertensive disorders, pre-eclampsia and 
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eclampsia, placental insufficiency, hypoxia and 
infection of the fetus in utero, and even abortion [2]. 
Timely detection and appropriate treatment 
initiated pyelonephritis can significantly improve the 
quality of life of the pregnant, prevent most 
complications both during pregnancy and in the 
postpartum period. 
According to clinical guidelines, the main 
treatment of pyelonephritis in pregnant women is 
antibiotic therapy, which would meet the basic 
requirements of safety and efficiency for both the 
mother and the fetus [9, 10]. Due to the large number 
of complications and the risk of pyelonephritis 
treatment should begin immediately after diagnosis, 
without waiting for the results of urine culture, that 
is, conduct empirical antibacterial drugs treatment of 
a wide spectrum of action, based on the most 
common causative agents of the disease [6, 8]. 
According to the Federal Clinical guidelines in 
2014 the drugs of choice in the treatment of 
pyelonephritis in pregnant women are cephalosporins 
III generation – ceftibuten, cefixime, cefotaxime, 
ceftriaxone, which have a broad spectrum of 
antibacterial activity and can be used at any stage of 
pregnancy. According to the USA classification of 
drugs FDA (Food and Drug Administration – FDA) 
cephalosporins are classified in safety of use during 
pregnancy [11, 12]. In addition to the cephalosporins, 
as a rational pharmacotherapy is possible to use the 
drug group monobactams – aztreonam (Category B 
classification FDA) [8]. 
With the ineffectiveness of these drugs, chronic 
and long-term course of the disease, in pregnant 
women for indications of alternative treatment may 
be applied -gentamicin + ampicillin (appointed after 
the II trimester) [9], category C by the FDA, [8, 13]. 
If you have restrictions on the use of 
aminoglycosides can be assigned to the group 
preparations of carbapenems, including meropenem, 
ertapenem, imipenem / cilastatin (Category B 
classification FDA) [9]. Also as can be seen 
altarnativnoy therapy drugs penicillins in 
combination with β-lactamase inhibitors – 
piperacillin / tazobactam, ticarcillin / clavulanate (B 
according to FDA) [9] and generation cephalosporin 
IV – cefepime. 
The most prominent common and useful drug 
for gestational pyelonephritis – amoxicillin / 
clavulanate, currently can not be recommended as 
empirical therapy, because of the large kolichesvo 
isolated strains of E. coli, resistant to the drug (up 
43.0%) [3]. Amoxicillin / clavulanic acid, as well as 
cephalosporin II generation (cefuroxime) appointed 
in pregnant women only after the culture results of 
urine on chuvsvitelnost to antibiotics. 
Contraindicated for use at any stage of 
pregnancy, fluoroquinolones, trimethoprim-
sulfamethoxazole (contraindicated in I and III 
trimester) and antibiotics group sulfonamides, 
tetracyclines, chloramphenicol, aminoglycosides 
individual (only for health reasons) [14, 15, 16, 17]. 
In view of the prevalence and social significance 
of the disease, a large number of complications, the 
empirical selection of antibacterial therapy at the 
beginning of treatment due to the timing of gestation 
and the severity of the patient's condition [18], it is 
expedient to hold a pharmacoepidemiological study 
in order to identify the preferences of physicians in 
the selection of Antimicrobial Chemotherapy (ACT) 
pyelonephritis pregnant . 
Objective: To analyze the choice of Belgorod 
region ACT doctors in the treatment of 
pyelonephritis in pregnancy. Compare the data with 
the results obtained as a result of the survey, which 
was conducted from February to April 2015, four 
federal districts of the Russian Federation – the 
Central, Volga, Urals and Far East. 
Materials and Methods: In this study based on 
the method of anonymous questionnaire in the 
framework of the second stage of the All-Russian 
pharmacoepidemiological study, "Epidemiology of 
the use of drugs in pregnant women", which was 
conducted from February to April 2015. All-Russian 
Pharmacoepidemiological 1066 questionnaires were 
analyzed in the study, of which 734 obstetricians and 
gynecologists, and 332 physician [19]. 
In a survey in the Belgorod region (BR) 94 
doctors took part (28.7% and 69.1% inpatient 
outpatient Profile, p <0, 01), of which 77 (81.9%) of 
Obstetricians and Gynecologists, 17 (18, 1%), 
physicians (p <0,0001), with a total work experience of 
less than 5 years – 21.3% of physicians, 5-10 years – 
26,6%, 10-20 years – 20.2% of doctors more than 
20 years and 26.6%. The survey was conducted on 
the basis of women's clinics, city policlinics and 
municipal race. Home Belgorod, as well as in the 
central district hospital. 
Information obtained from the survey were 
entered and processed using MicrosoftExel program. 
Main part: 
To determine the preferences of physicians in 
the treatment of acute pyelonephritis in the 
questionnaire presented a list of the most commonly 
used drugs: 
• Penicillin – benzyl penicillin, ampicillin,
amoxicillin, amoxicillin / clavulanate; 
Chuhareva N.A., Bontsevich R.A., ,Shchurovskaya K.V., Denisova D.S. The choice of 
antimicrobial therapy among physicians in the treatment of gestational pyelonephritis. 
Research result: pharmacology and clinical pharmacology. Vol. 2, №3 (2016): 46-50. 
48 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
• Cephalosporins – cefazolin, cefuroxime,
cefotaxime, ceftriaxone, cefixime ("Supraks"), 
cefepime; 
• Macrolides – erythromycin, spiramycin,
josamycin, clarithromycin, azithromycin; 
• Fluoroquinolones – norfloxacin, ofloxacin,
pefloxacin, ciprofloxacin, "Avelox", "tavanic"; 
• Aminoglycosides – steptomitsin, gentamicin,
amikacin; 
• Nitroxoline;
• Fosfomycin (Monural);
• Nitrofurans (furadonin, Furamat, Furagin);
• lincomycin, clindamycin, vancomycin, 
meropenem; 
As it was provided for your answer and the 
option "not to appoint, send to another specialist." 
Based on clinical guidelines for the treatment of 
pyelonephritis in pregnant women as a starting 
cephalosporin III generation empirical therapy 
(cefotaxime, ceftriaxone and cefixime), 56.4% of 
physicians chose BR (63.6% of obstetricians and 
gynecologists and 23,5% of the therapist, p = 0,002) 
and 46.1% of physicians All-Russia study (p = 0,054). 
Amoxicillin / clavulanate (without preliminary 
urine culture sensitivity to the drug) 50.0% of 
physicians chose the Belgorod region (57.1% of 
obstetricians and gynecologists and 17.7% of 
physicians, p = 0,003) and 49.1% of the doctors at 
the All-Russia study (p = 0,861). 
Cephalosporin II generation (cefuroxime) (also 
without preliminary urine culture sensitivity to the drug) 
chose only obstetricians Belgorod region (7.8%) and 
physicians All-Russia study (8,3%), p = 0.886. 
A large number of responses were given 
ineffective as a therapy of pyelonephritis is not 
protected against beta-lactamase penicillins – CP 
doctors pointed them in 55.3% of the questionnaires 
(51.9% and 70.6% of obstetricians Physicians, p = 
0,161), the All-Russian doctors in the study 32.9% of 
the questionnaires (p <0,0001). Cefazolin 
(cephalosporin II generation) 27.7% of physicians 
chose the Belgorod region (32.5% of obstetrician-
gynecologist and 5.9% of the therapist, p = 0.02) and 
15.6% of physicians All-Russia study, p = 0.002. 
Macrolides having low activity against gram-
negative microflora was given to 31.9% of the 
responses in the BR (37.7% of obstetricians and 
gynecologists and internists 5.9%, p = 0.01) and 
18.4% of responses at All-Russia study, p = 0.0015. 
Fosfomycin, a drug that is used only for the 
treatment of cystitis and bacteriuria, indicated in their 
questionnaires, 30.9% of physicians BR (32.5% and 
23.5% of obstetricians Physicians, p = 0.470) and 
19.6% of doctors of All-Russian Research, p = 0.009. 
Alternative drugs in the treatment of gestational 
pyelonephritis – aminoglycosides, vancomycin – not 
chosen any one of the doctors surveyed BR and in 
rare cases, doctors noticed All-Russia study (0.4% 
and 0.5%, respectively), p> 0.5. The cephalosporin 
IV generation, notes BR 4,2% of doctors (3.9% and 
5.9%, obstetricians physicians) and 5.2% of 
physicians All-Russia study, p = 0,702. 
Absolutely contraindicated in the treatment of 
gestational pyelonephritis fluoroquinolones are listed 
in the individual questionnaires BR physicians 
(2.1%) and the All-Russia survey (2.2%). 
Send their patients for treatment to another 
specialist doctors decide 26.6% BR (28.7% of 
obstetricians and gynecologists and 17.6% of 
physicians, p = 0.356) and 32.3% of All-Russian 
research physicians (p = 0.257). Compare tactics 
ACT doctors BR and All-Russia study are shown in 
Table 1 and Figure 1. 
Table 1 
Comparison of tactics AMT doctors Belgorod Region and All-Russia Research 
The drug 
Doctors of Belgorod Region 
Doctors of All-Russia 
Research р 
N=94 Abs. % N=1066 Abs. % 
Amoxicillin / clavulanate 47 50,0 523 49,1 0,861 
Cephalosporin I generation 26 27,7 166 15,6 0,002 
Cephalosporin II generation 6 6,4 88 8,3 0,523 
Cephalosporin III generation 53 56,3 491 46,1 0,054 
Cephalosporin IV generation 4 4,2 55 5,2 0,702 
Not protected penicillins 52 55,3 350 32,9 <0,0001 
Macrolides 30 31,9 196 18,4 0,0015 
Fosfomycin 29 30,9 209 19,6 0,009 
Fluoroquinolones 2 2,1 23 2,2 0,938 
Aminoglycosides 0 0 4 0,4 >0,5 
Vancomycin 0 0 5 0,5 >0,5 
Do not prescribe pharmacotherapy 25 26,6 344 32,3 0,257 
(Note: p -Hi-square Pearson) 
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Figure 1. The purpose frequency pyelonefrite drugs in pregnant women among obstetrician-gynecologists 
and internists Belgorod region of the Russian Federation 
Conclusion: 
According to the data of the survey, about half 
of the doctors of the Belgorod region and the All-
Russian Research prescribe rational pharmacotherapy 
in the treatment of gestational pyelonephritis (in 
particular, Cephalosporin III generation), p = 0.054. 
From about the same, but without specifying 
what perparaty data can be allocated only after urine 
culture sensitivity operedeleniya rate doctors opt to 
amoxicillin / clavulanate (p = 0.861) and 
cephalosporin II generation (p = 0.523). 
Regardless of the national recommendations, the 
canons of rational antibiotic therapy, doctors BR and 
All-Russian Research continue to prescribe their 
patients previously ineffective drugs in the treatment 
of pyelonephritis – macrolides (p = 0.0015) and 
fosfomycin (p = 0.009). 
Reserve antimicrobials – amnoglikozidy, 
vancomycin, meropenem – chose only doctors All-
Russian Research; cephalosporin IV generation was 
given roughly equal number of votes (p = 0.702), 
however, none of the doctors did not indicate that 
they prescribe them for health reasons, in the case 
where the appointment of benefit to the mother 
outweighs the potential risk for the development of 
the fetus. 
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Conclusions: 
According to the survey, more than 68% of 
obstetricians and gynecologists and internists Belgorod 
Region and All-Russia research independently carried 
out the treatment of pyelonephritis in pregnancy. An 
analysis of the responses of physicians BR and All-
Russia research tactics destination ACT found that only 
half of practitioners prescribed therapy based on the 
rational use of antimicrobials. survey results once again 
demonstrate the relevance of women's adequate therapy 
problems during pregnancy with concomitant 
pathology. 
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